Cargando…
Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era
BACKGROUND: Pathological and clinical stage are associated with prostate cancer-specific survival after prostatectomy. With PSA screening, the post-surgery prognostic utility of clinical stage is debatable in studies seeking to identify new biomarkers. Few studies have investigated clinical stage an...
Autores principales: | Chen, Maxine M., Jahn, Jaquelyn L., Barber, John R., Han, Misop, Stampfer, Meir J., Platz, Elizabeth A., Penney, Kathryn L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289430/ https://www.ncbi.nlm.nih.gov/pubmed/32525914 http://dx.doi.org/10.1371/journal.pone.0234391 |
Ejemplares similares
-
Multiparametric MRI in the PSA Screening Era
por: George, Arvin K., et al.
Publicado: (2014) -
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy
por: Heaphy, Christopher M, et al.
Publicado: (2022) -
Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence
por: Truong, M, et al.
Publicado: (2012) -
Metastatic prostate cancer in the modern era of PSA screening
por: Fontenot, Philip A., et al.
Publicado: (2017) -
Replication of a Genetic Variant for Prostate Cancer-Specific Mortality
por: Penney, Kathryn L., et al.
Publicado: (2015)